It remains difficult to distinguish adenoid cystic carcinoma (ACC) from polymorphous low-grade adenocarcinoma (PLGA). Although these neoplasms exhibit nearly similar histologic patterns, their biologic behavior is significantly different. This study was carried out in an attempt to overcome the histological overlap between these tumors using immunohistochemical method for c-kit and galectin-3 proteins on twenty cases of salivary gland tumors including twelve ACC and eight PLGA. Results revealed positive cytoplasmic reactivity for c-kit in 100% of ACC cases and only in 25% of PLGA. On the other hand, galectin-3 expression was observed in 100% of both ACC and PLGA cases. Moreover, solid variant of ACC showed overexpression of both proteins than cribriform and tubular subtypes. Significant positive correlation between the two studied proteins in ACC and PLGA was also observed (p < 0.05). Upon these results, over expression of c-kit and galectin-3 in ACC cases supports the concept of solid variant as a high-grade tumor. Moreover, c-kit may be used as a helpful marker to distinguish ACC from PLGA in cases where the diagnosis can be challenging.
Neville BW, Damm DD, Allen CM, Bouquot JE (2009): Oral and maxillofacial pathology, 2nd ed. Saunders, Philadelphia, PA
Bouquot J.E. , '', in Oral and maxillofacial pathology , (2009 ) -.
Rapidis AD, Givalos N, Gakiopoulou H, Faratzis G, Stavrianos SD, Vilos GA, Douzinas EE, Patsouris E: Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol 41, 328–335 (2005)
Patsouris E. , 'Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature ' (2005 ) 41 Oral Oncol : 328 -335.
Fordice J, Kershaw C, El-Naggar A, Goepfert H: Adenoid cystic carcinoma of the head and neck: Predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 125, 149–152 (1999)
Goepfert H. , 'Adenoid cystic carcinoma of the head and neck: Predictors of morbidity and mortality ' (1999 ) 125 Arch Otolaryngol Head Neck Surg : 149 -152.
Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, Haffty BG: Adenoid cystic carcinoma: A retrospective clinical review. Int J Cancer 96, 149–158 (2001)
Haffty B.G. , 'Adenoid cystic carcinoma: A retrospective clinical review ' (2001 ) 96 Int J Cancer : 149 -158.
Buchner A, Merrell PW, Carpenter WM: Relative frequency of intra-oral minor salivary gland tumors: A study of 380 cases from northern California and comparison to reports from other parts of the world. J Oral Pathol Med 36, 207–214 (2007)
Carpenter W.M. , 'Relative frequency of intra-oral minor salivary gland tumors: A study of 380 cases from northern California and comparison to reports from other parts of the world ' (2007 ) 36 J Oral Pathol Med : 207 -214.
Paleri V, Robinson M, Bradley P: Polymorphous low grade adenocarcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 16, 163–169 (2008)
Bradley P. , 'Polymorphous low grade adenocarcinoma of the head and neck ' (2008 ) 16 Curr Opin Otolaryngol Head Neck Surg : 163 -169.
Jaso J, Malhotra R: Adenoid cystic carcinoma. Arch Pathol Lab Med 135, 511–515 (2011)
Malhotra R. , 'Adenoid cystic carcinoma ' (2011 ) 135 Arch Pathol Lab Med : 511 -515.
Nagao T, Gaffey TA, Kay PA, Minato H, Serizawa H, Lewis JE: Polymorphous low-grade adenocarcinoma of the major salivary glands: Report of three cases in an unusual location. Histopathology 44, 164–171 (2004)
Lewis J.E. , 'Polymorphous low-grade adenocarcinoma of the major salivary glands: Report of three cases in an unusual location ' (2004 ) 44 Histopathology : 164 -171.
Batsaki JG, Pinkston GR, Luna MA, Byers RM, Scruba JJ, Tilley GW: Adenocarcinomas of the oral cavity: A clinicopathological study of terminal duct carcinomas. J Laryngol Otol 97, 825–835 (1983)
Tilley G.W. , 'Adenocarcinomas of the oral cavity: A clinicopathological study of terminal duct carcinomas ' (1983 ) 97 J Laryngol Otol : 825 -835.
Pelkey TJ, Mills SE: Histologic transformation of polymorphous low-grade adenocarcinoma of salivary gland. Am J Clin Pathol 111, 785–791 (1999)
Mills S.E. , 'Histologic transformation of polymorphous low-grade adenocarcinoma of salivary gland ' (1999 ) 111 Am J Clin Pathol : 785 -791.
Sunil S, Sreenivasan BS, Jisha T, Soma S, Jubin T, Antony G, Gopakumar D: Polymorphous low grade adenocarcinoma - Case report and review of literature. Oral & Maxillofac Pathol J 1(2), (2010)
Gopakumar D. , '', in Oral & Maxillofac Pathol J , (2010 ) -.
Young S, Leon M, Talerman A, Teresi M, Emmandi L: Polymorphous low-grade adenocarcinoma of the vulva and vagina: A tumor resembling adenoid cystic carcinoma. Int J Surg Pathol 11, 43–49 (2003)
Emmandi L. , 'Polymorphous low-grade adenocarcinoma of the vulva and vagina: A tumor resembling adenoid cystic carcinoma ' (2003 ) 11 Int J Surg Pathol : 43 -49.
Ellis GL, Auclair PL (1995): Tumors of the salivary glands. In: Atlas of tumor pathology, ed Rosai J, Armed Forces Institute of Pathology, Washington, D.C., pp. 203–228
Auclair P.L. , '', in Atlas of tumor pathology , (1995 ) -.
Evans HL, Batsakis JG: Polymorphous low grade adenocarcinoma of minor salivary glands: A study of 14 cases of a distinctive neoplasm. Cancer 53, 935–942 (1984)
Batsakis J.G. , 'Polymorphous low grade adenocarcinoma of minor salivary glands: A study of 14 cases of a distinctive neoplasm ' (1984 ) 53 Cancer : 935 -942.
Darling MR, Schneider JW, Phillips VM: Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: A review and comparison of immunohistochemical markers. Oral Oncol 38, 641–645 (2002)
Phillips V.M. , 'Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: A review and comparison of immunohistochemical markers ' (2002 ) 38 Oral Oncol : 641 -645.
Barnes L, Eveson JW, Reichart P, Sidransky D (2005): World Health Organization classification of tumors: Pathology and genetics of head and neck tumors. IARC Press, Lyon
Sidransky D. , '', in World Health Organization classification of tumors: Pathology and genetics of head and neck tumors , (2005 ) -.
Vrielinck LJ, Ostyn F, van Damme B, van den Bogaert W, Fossion E: The significance of perineural spread in adenoid cystic carcinoma of the major and minor salivary glands. Int J Oral Maxillofac Surg 17, 190–193 (1988)
Fossion E. , 'The significance of perineural spread in adenoid cystic carcinoma of the major and minor salivary glands ' (1988 ) 17 Int J Oral Maxillofac Surg : 190 -193.
Tomich C (1991): Adenoid cystic carcinoma. In: Surgical pathology of the salivary glands, ed Ellis G, WB Saunders, Philadelphia, PA, pp. 333–349
Tomich C. , '', in Surgical pathology of the salivary glands , (1991 ) -.
Ellis GL, Auclair PL (1996): Tumors of the salivary glands. Armed Forces Institute of Pathology, Washington, D.C.
Auclair P.L. , '', in Tumors of the salivary glands , (1996 ) -.
Mino M, Pilch BZ, Faquin WC: Expression of KIT (CD117) in neoplasms of the head and neck: An ancillary marker for adenoid cystic carcinoma. Mod Pathol 16, 1224–1231 (2003)
Faquin W.C. , 'Expression of KIT (CD117) in neoplasms of the head and neck: An ancillary marker for adenoid cystic carcinoma ' (2003 ) 16 Mod Pathol : 1224 -1231.
Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE: Adenoid cystic carcinoma of the head and neck — A 20 years’ experience. Int J Oral Maxillofac Surg 33, 25–31 (2004)
Hausamen J.E. , 'Adenoid cystic carcinoma of the head and neck — A 20 years’ experience ' (2004 ) 33 Int J Oral Maxillofac Surg : 25 -31.
Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP: Polymorphous low grade adenocarcinoma: A clinicopathologic study of 164 cases. Cancer 15, 207–219 (1999)
Kessler H.P. , 'Polymorphous low grade adenocarcinoma: A clinicopathologic study of 164 cases ' (1999 ) 15 Cancer : 207 -219.
Evans HL, Luna MA: Polymorphous low-grade adenocarcinoma: A study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas. Am J Surg Pathol 24, 1319–1328 (2000)
Luna M.A. , 'Polymorphous low-grade adenocarcinoma: A study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas ' (2000 ) 24 Am J Surg Pathol : 1319 -1328.
Penner CR, Folpe AL, Budnick SD: C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low grade adenocarcinoma. Mod Pathol 15, 687–691 (2002)
Budnick S.D. , 'C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low grade adenocarcinoma ' (2002 ) 15 Mod Pathol : 687 -691.
Jeng YM, Lin CY, Hsu HC: Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett 154, 107–111 (2000)
Hsu H.C. , 'Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma ' (2000 ) 154 Cancer Lett : 107 -111.
Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6, 3341–3351 (1987)
Ullrich A. , 'Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand ' (1987 ) 6 EMBO J : 3341 -3351.
d’Auriol L, Mattei MG, Andre C, Galibert F: Localization of the human c-kit protooncogene on the q11–q12 region of chromosome 4. Hum Genet 78, 374–376 (1988)
Galibert F. , 'Localization of the human c-kit protooncogene on the q11–q12 region of chromosome 4 ' (1988 ) 78 Hum Genet : 374 -376.
Fletcher JA: Role of KIT and platelet-derived growth factor receptors as oncoproteins. Semin Oncol 31, 4–11 (2004)
Fletcher J.A. , 'Role of KIT and platelet-derived growth factor receptors as oncoproteins ' (2004 ) 31 Semin Oncol : 4 -11.
Hussein MR, Haemel AK, Wood GS: Apoptosis and melanoma: Molecular mechanisms. J Pathol 199, 275–288 (2003)
Wood G.S. , 'Apoptosis and melanoma: Molecular mechanisms ' (2003 ) 199 J Pathol : 275 -288.
Smithey BE, Pappo AS, Hill DA: C-kit expression in pediatric solid tumors: A comparative immunohistochemical study. Am J Surg Pathol 26, 486–492 (2002)
Hill D.A. , 'C-kit expression in pediatric solid tumors: A comparative immunohistochemical study ' (2002 ) 26 Am J Surg Pathol : 486 -492.
Pelosi G, Barisella M, Pasini F, Leon ME, Veronesi G, Spaggiari L, Fraggetta F, Iannucci A, Masullo M, Sonzogni A, Maffini F, Viale G: CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: Relevance to prognosis in a subset of adenocarcinoma patients. Mod Pathol 17, 711–721 (2004)
Viale G. , 'CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: Relevance to prognosis in a subset of adenocarcinoma patients ' (2004 ) 17 Mod Pathol : 711 -721.
Scobie JV, Acs G, Bandera CA, Blank SV, Wheeler JE, Pasha TL, Salscheider M, Zhang PJ: C-kit immunoreactivity in endometrial adenocarcinomas and its clinicopathologic significance. Int J Gynecol Pathol 22, 149–155 (2003)
Zhang P.J. , 'C-kit immunoreactivity in endometrial adenocarcinomas and its clinicopathologic significance ' (2003 ) 22 Int J Gynecol Pathol : 149 -155.
Krams M, Parwaresch R, Sipos B, Heidorn K, Harms D, Rudolph P: Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis. Oncogene 23, 588–595 (2004)
Rudolph P. , 'Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis ' (2004 ) 23 Oncogene : 588 -595.
Raspollini MR, Amunni G, Villanucci A, Baroni G, Taddei A, Taddei GL: c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: An immunocytochemical study. Ann Oncol 15, 594–597 (2004)
Taddei G.L. , 'c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: An immunocytochemical study ' (2004 ) 15 Ann Oncol : 594 -597.
Barondes SH, Cooper DN, Gitt MA, Leffler H: Galectins structure and function of a large family of animal lectins. J Biol Chem 269, 20807–20810 (1994)
Leffler H. , 'Galectins structure and function of a large family of animal lectins ' (1994 ) 269 J Biol Chem : 20807 -20810.
Krześlak A, Lipiñska A: Galectin-3 as a multifunctional protein. Cell Mol Biol Lett 9, 305–328 (2004)
Lipiñska A. , 'Galectin-3 as a multifunctional protein ' (2004 ) 9 Cell Mol Biol Lett : 305 -328.
Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A: Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156, 899–909 (2000)
Raz A. , 'Galectin-3 induces endothelial cell morphogenesis and angiogenesis ' (2000 ) 156 Am J Pathol : 899 -909.
Honjo Y, Nangia-Makker P, Inohara H, Raz A: Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 7, 661–668 (2001)
Raz A. , 'Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells ' (2001 ) 7 Clin Cancer Res : 661 -668.
Raz A, Zhu DG, Hogan V, Shah N, Raz T, Karkash R, Pazerini G, Carmi P: Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer 46, 871–877 (1990)
Carmi P. , 'Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis ' (1990 ) 46 Int J Cancer : 871 -877.
Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A: Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57, 5272–5276 (1997)
Raz A. , 'Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family ' (1997 ) 57 Cancer Res : 5272 -5276.
Sakaki M, Fukumori T, Fukawa T, Elsamman E, Shiirevnyamba A, Nakatsuji H, Kanayama HO: Clinical significance of galectin-3 in clear cell renal cell carcinoma. J Med Invest 57, 152–157 (2010)
Kanayama H.O. , 'Clinical significance of galectin-3 in clear cell renal cell carcinoma ' (2010 ) 57 J Med Invest : 152 -157.
Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, Hattori K, Tomiyama Y, Raz A, Kubo T: Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6, 4635–4640 (2000)
Kubo T. , 'Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma ' (2000 ) 6 Clin Cancer Res : 4635 -4640.
Xu XC, el-Naggar AK, Lotan R: Differential expression of galectin-1 and galectin-3 in thyroid tumors, potential diagnostic implications. Am J Pathol 147, 815–822 (1995)
Lotan R. , 'Differential expression of galectin-1 and galectin-3 in thyroid tumors, potential diagnostic implications ' (1995 ) 147 Am J Pathol : 815 -822.
Wang Y, Nangia-Makker P, Tait L, Balan V, Hogan V, Pienta KJ, Raz A: Regulation of prostate cancer progression by galectin-3. Am J Pathol 174, 1515–1523 (2009)
Raz A. , 'Regulation of prostate cancer progression by galectin-3 ' (2009 ) 174 Am J Pathol : 1515 -1523.
Castronovo V, Van Den Brûe FA, Jackers P, Clausse N, Liu FT, Gillet C, Sobel ME: Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 179, 43–48 (1996)
Sobel M.E. , 'Decreased expression of galectin-3 is associated with progression of human breast cancer ' (1996 ) 179 J Pathol : 43 -48.
van den Brule FA, Buicu C, Berchuck A, Bast RC, Deprez M, Liu FT, Cooper DN, Pieters C, Sobel ME, Castronovo V: Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. Hum Pathol 27, 1185–1191 (1996)
Castronovo V. , 'Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma ' (1996 ) 27 Hum Pathol : 1185 -1191.
Piantelli M, Iacobelli S, Almadori G, Iezzi M, Tinari N, Natoli C, Cadoni G, Lauriola L, Ranelletti FO: Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. J Clin Oncol 20, 3850–3856 (2002)
Ranelletti F.O. , 'Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma ' (2002 ) 20 J Clin Oncol : 3850 -3856.
Plzák J, Betka J, Smetana K Jr, Chovanec M, Kaltner H, André S, Kodet R, Gabius HJ: Galectin-3 an emerging prognostic indicator in advanced head and neck carcinoma. Eur J Cancer 40, 2324–2330 (2004)
Gabius H.J. , 'Galectin-3 an emerging prognostic indicator in advanced head and neck carcinoma ' (2004 ) 40 Eur J Cancer : 2324 -2330.
Beltran D, Faquin WC, Gallagher G, August M: Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg 64, 415–423 (2006)
August M. , 'Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma ' (2006 ) 64 J Oral Maxillofac Surg : 415 -423.
Miliaras D, Karasavvidou F, Papanikolaou A, Sioutopoulou D: KIT expression in fetal, normal adult, and neoplastic renal tissues. J Clin Pathol 57, 463–466 (2004)
Sioutopoulou D. , 'KIT expression in fetal, normal adult, and neoplastic renal tissues ' (2004 ) 57 J Clin Pathol : 463 -466.
Pan CC, Chen PC, Chiang H: Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 121, 878–883 (2004)
Chiang H. , 'Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma ' (2004 ) 121 Am J Clin Pathol : 878 -883.
Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr: KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 12, 956–960 (1999)
Frierson H.F. , 'KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma ' (1999 ) 12 Mod Pathol : 956 -960.
Arber DA, Tamayo R, Weiss LM: Paraffin section detection of the c-kit gene product (CD117) in human tissues: Value in the diagnosis of mast cell disorders. Hum Pathol 29, 498–504 (1998)
Weiss L.M. , 'Paraffin section detection of the c-kit gene product (CD117) in human tissues: Value in the diagnosis of mast cell disorders ' (1998 ) 29 Hum Pathol : 498 -504.
Albers E, Lawrie T, Harrell JH, Yi ES: Tracheobronchial adenoid cystic carcinoma: A clinicopathologic study of 14 cases. Chest 125, 1160–1165 (2004)
Yi E.S. , 'Tracheobronchial adenoid cystic carcinoma: A clinicopathologic study of 14 cases ' (2004 ) 125 Chest : 1160 -1165.
Edwards PC, Bhuiya T, Kelsch RD: C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95, 586–593 (2002)
Kelsch R.D. , 'C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma ' (2002 ) 95 Oral Surg Oral Med Oral Pathol Oral Radiol Endod : 586 -593.
Epivatianos A, Poulopoulos A, Dimitrakopoulos I, Andreadis D, Nomikos A, Vlahou S, Papazoglou G, Barbatis C: Application of alpha-smooth muscle actin and c-kit in the differential diagnosis of adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Oral Oncol 43, 67–76 (2007)
Barbatis C. , 'Application of alpha-smooth muscle actin and c-kit in the differential diagnosis of adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma ' (2007 ) 43 Oral Oncol : 67 -76.
Freier K, Flechtenmacher C, Walch A, Devens F, Mühling J, Lichter P, Joos S, Hofele C: Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland. Oral Oncol 41, 934–939 (2005)
Hofele C. , 'Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland ' (2005 ) 41 Oral Oncol : 934 -939.
Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E: Adenoid cystic carcinoma with high-grade transformation: A report of 11 cases and a review of the literature. Am J Surg Pathol 31, 1683–1694 (2007)
Leon Barnes E. , 'Adenoid cystic carcinoma with high-grade transformation: A report of 11 cases and a review of the literature ' (2007 ) 31 Am J Surg Pathol : 1683 -1694.
Meer S, Singh S, Altini M: C-kit and bcl-2 are not useful markers in differentiating adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. ISRN Pathology 2011, Article ID 415614 (2011)
Altini M. , '', in ISRN Pathology 2011, Article ID 415614 , (2011 ) -.
Schwarz S, Müller M, Ettl T, Stockmann P, Zenk J, Agaimy A: Morphological heterogeneity of oral salivary gland carcinomas: A clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Int J Clin Exp Pathol 4, 336–348 (2011)
Agaimy A. , 'Morphological heterogeneity of oral salivary gland carcinomas: A clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma ' (2011 ) 4 Int J Clin Exp Pathol : 336 -348.
Andreadis D, Epivatianos A, Poulopoulos A, Nomikos A, Papazoglou G, Antoniades D, Barbatis C: Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours. Oral Oncol 42, 57–65 (2006)
Barbatis C. , 'Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours ' (2006 ) 42 Oral Oncol : 57 -65.
Oprea G, Khalil Z, Mesa H: Value of c-kit (CD117) staining in the differential diagnosis of basaloid tumors of the head and neck. Mod Pathol 15, 222A–223A (2002)
Mesa H. , 'Value of c-kit (CD117) staining in the differential diagnosis of basaloid tumors of the head and neck ' (2002 ) 15 Mod Pathol : 222A -223A.
Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A: Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156, 899–909 (2000)
Raz A. , 'Galectin-3 induces endothelial cell morphogenesis and angiogenesis ' (2000 ) 156 Am J Pathol : 899 -909.
Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55, 74–108 (2005)
Pisani P. , 'Global cancer statistics, 2002 ' (2005 ) 55 CA Cancer J Clin : 74 -108.
Piantelli M, Iacobelli S, Almadori G, Iezzi M, Tinari N, Natoli C, Cadoni G, Lauriola L, Ranelletti FO: Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. J Clin Oncol 20, 3850–3856 (2002)
Ranelletti F.O. , 'Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma ' (2002 ) 20 J Clin Oncol : 3850 -3856.
Xu XC, Sola Gallego JJ, Lotan R, El-Naggar AK: Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms. Int J Oncol 17, 271–276 (2000)
El-Naggar A.K. , 'Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms ' (2000 ) 17 Int J Oncol : 271 -276.